RxDoctor Payments Data

Ayaz Biviji, MD

Orthopedic Surgery · Orange, CANPI 1023008422

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,508 of the $8,215 with a category attached, or 67.1%. 27 manufacturers reported payments, led by Arthrex at 29.6% of the total. Reporting peaked in 2019 at $2,966 and has fallen 73.1% since, to $798 in 2025.

$8,215in general payments, 2019–2025

Across 96 payments — averaging $85.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Stryker$2K
  • Exactech, Inc.$940
  • Smith+Nephew$641
  • Johnson & Johnson$580
  • Davol Inc.$435
  • plus $1K from 21 others

What the payments were for

  • Travel & lodging$7799%
  • Food & beverage$5,50867%
  • Education$1,92823%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,215 in reported general payments places this provider in the 80th percentile of 130 orthopedic surgery providers in California.

See all orthopedic surgery providers in California

Medicare billing

Part B allowed, 2024
$343,157
Medicare patients
407
Services billed
4,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib59$912
Diclofenac Sodium92$710
Etodolac19$246
Methylprednisolone41$226
Amoxicillin92$138
Gabapentin43$112
Doxycycline Hyclate11$100
Cephalexin19$84
Cyclobenzaprine Hcl21$74

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →